A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

  • Revonult@lemmy.world
    link
    fedilink
    arrow-up
    4
    ·
    8 months ago

    Okay so everyone is different but I just found out my non-diabetic hypoglycemia was almost entirly caused by my stimulant ADHD medication. I had been taking it for 12+ years and always thought the hypoglycemia was just how my body was, but it has been night and day. It was very hard to move away the the meds but but I know EXACTLY what you mean by the sudden “dying of sugar crash”. Obviously the ADHD still needs treat but I will be moving to a non-stimulant for treatment.

    • flicker@kbin.social
      link
      fedilink
      arrow-up
      1
      ·
      8 months ago

      I’m upvoting you and I’m going to share your story with others but unfortunately I know this isn’t the case with me, as I was adult diagnosis ADHD and dealt with the hypoglycemia since elementary school. I only tried stimulant medication for the first time two years ago.

      But I wonder if any studies have been done about frequency of ADHD and hypoglycemia comorbidities! Seems promising!